• 1.

    Martin P, et al. Executive summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int 2022; 102:12281237. doi: 10.1016/j.kint.2022.07.012

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Ali S, et al. Improving access to the treatment of hepatitis C in low- and middle-income countries: Evaluation of a patient assistance programme. Int J Clin Pharm 2021; 43:958968. doi: 10.1007/s11096-020-01202-1

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Molnar MZ, et al. Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans. Hepatology 2015; 61:14951502. doi: 10.1002/hep.276640

    • PubMed
    • Search Google Scholar
    • Export Citation

Direct-Acting Antiviral Therapies for Patients with Kidney Diseases and Hepatitis C Virus Infection

James E. Dinulos James E. Dinulos and Meghan E. Sise, MD, are with the Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA.

Search for other papers by James E. Dinulos in
Current site
Google Scholar
PubMed
Close
and
Meghan E. Sise James E. Dinulos and Meghan E. Sise, MD, are with the Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA.

Search for other papers by Meghan E. Sise in
Current site
Google Scholar
PubMed
Close
Restricted access
Save